Ellington Management Group’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-47,100
Closed -$426K 911
2013
Q4
$426K Buy
47,100
+28,100
+148% +$254K 0.15% 217
2013
Q3
$120K Buy
+19,000
New +$120K 0.02% 715